MicroRNA therapeutics in preclinical cancer models.
Kim, Minlee, Andrea L Kasinski, and Frank J Slack. 2011. “MicroRNA Therapeutics in Preclinical Cancer Models.”. The Lancet. Oncology 12 (4): 319-21.
Search
Search results
2980 results found
Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk.
Pelletier, Cory, William C Speed, Trupti Paranjape, Katie Keane, Rachel Blitzblau, Antoinette Hollestelle, Kyan Safavi, et al. 2011. “Rare BRCA1 Haplotypes Including 3’UTR SNPs Associated With Breast Cancer Risk.”. Cell Cycle (Georgetown, Tex.) 10 (1): 90-9.
Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project.
Gerstein, Mark B, Zhi John Lu, Eric L Van Nostrand, Chao Cheng, Bradley I Arshinoff, Tao Liu, Kevin Y Yip, et al. 2010. “Integrative Analysis of the Caenorhabditis Elegans Genome by the ModENCODE Project.”. Science (New York, N.Y.) 330 (6012): 1775-87.
Stem cells: Big roles for small RNAs.
Slack, Frank J. 2010. “Stem Cells: Big Roles for Small RNAs.”. Nature 463 (7281): 616.
Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging studies of 3D co-culture models.
Struth, Eric, Maryam Labaf, Vida Karimnia, Yiran Liu, Gwendolyn Cramer, Joanna B Dahl, Frank J Slack, Kourosh Zarringhalam, and Jonathan P Celli. 2024. “Drug Resistant Pancreatic Cancer Cells Exhibit Altered Biophysical Interactions With Stromal Fibroblasts in Imaging Studies of 3D Co-Culture Models.”. BioRxiv : The Preprint Server for Biology.
Cognition-associated long noncoding RNAs are dysregulated upon severe COVID-19.
Lee, Jonathan D, Isaac H Solomon, Frank J Slack, and Maria Mavrikaki. 2024. “Cognition-Associated Long Noncoding RNAs Are Dysregulated Upon Severe COVID-19.”. Frontiers in Immunology 15: 1290523.
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy.
Yu, Haisheng, Jing Liu, Xia Bu, Zhiqiang Ma, Yingmeng Yao, Jinfeng Li, Tiantian Zhang, et al. 2024. “Targeting METTL3 Reprograms the Tumor Microenvironment to Improve Cancer Immunotherapy.”. Cell Chemical Biology 31 (4): 776-791.e7.
Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics.
Pradeep, Sai Pallavi, Shipra Malik, Frank J Slack, and Raman Bahal. 2023. “Unlocking the Potential of Chemically Modified Peptide Nucleic Acids for RNA-Based Therapeutics.”. RNA (New York, N.Y.) 29 (4): 434-45.
Is Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3.
Vancura, Adrienne, Alejandro H Gutierrez, Thorben Hennig, Carlos Pulido-Quetglas, Frank J Slack, Rory Johnson, and Simon Haefliger. 2022. “Is Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3.”. Non-Coding RNA 8 (6).
ADAR1 and its implications in cancer development and treatment.
Baker, Allison R, and Frank J Slack. 2022. “ADAR1 and Its Implications in Cancer Development and Treatment.”. Trends in Genetics : TIG 38 (8): 821-30.